/PRNewswire/ Evozyne, Inc., an adaptive biology company pioneering evolution-based design of proteins, founded by Paragon Biosciences, announced today that.
/PRNewswire/ Emalex Biosciences, Inc. ("Emalex"), a biopharmaceutical company focused on developing treatments for central nervous system (CNS) movement.
/PRNewswire/ Emalex Biosciences, Inc. ("Emalex"), a biopharmaceutical company focused on developing treatments for central nervous system (CNS) movement.
/PRNewswire/ Emalex Biosciences, Inc. ("Emalex"), a biopharmaceutical company focused on developing treatments for central nervous system (CNS) movement.
/PRNewswire/ Paragon Biosciences is proud to announce that it has been certified as a Great Place to Work®. This prestigious distinction is entirely survey.